ImmuPharma plc (LON:IMM – Get Free Report)’s share price passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 2.48 ($0.03) and traded as high as GBX 3 ($0.04). ImmuPharma shares last traded at GBX 2.80 ($0.04), with a volume of 3,469,165 shares.
ImmuPharma Stock Performance
The company’s fifty day moving average price is GBX 3.92 and its 200 day moving average price is GBX 2.48. The firm has a market capitalization of £11.92 million, a price-to-earnings ratio of -4.85 and a beta of 1.53.
About ImmuPharma
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
Further Reading
- Five stocks we like better than ImmuPharma
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- D-Wave: Multiple Use Cases Emerge Following Quantum Supremacy
- Earnings Per Share Calculator: How to Calculate EPS
- Amazon Falls Back to a Key Support Line: Here’s How to Play It
- How is Compound Interest Calculated?
- Buffett Trims Equities, But Still Keeps Buying This Stock
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
